A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The overall objective of this trial is to evaluate the efficacy and safety of repeated Lamazym i.v. treatment, compared with placebo, in subjects 5-35 years of age with alpha-Mannosidosis
Epistemonikos ID: 3c90219dd6ba427a70d6bd9767211aebf38d0891
First added on: May 11, 2024